Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Clinical trial NCT06751602 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06751602
- Sponsor
- The Methodist Hospital Research Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-11
- Primary completion
- 2027-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.